The THALES Trial: Ticagrelor and Aspirin vs Aspirin Alone in Acute Ischemic Stroke or TIA - REBEL EM - Emergency Medicine Blog
Antiplatelet Therapy for Secondary Stroke Prevention in Patients with Ischemic Stroke or Transient Ischemic Attack
EMNote.org - EMNote
290 Stroke and TIA Triple Distilled - The Curbsiders
Dual antiplatelet therapy with ticagrelor may increase the risk of all bleeding events in patients with minor strokes or high risk TIAs: a meta-analysis | Stroke and Vascular Neurology
Medical therapies (Chapter 24) - Transient Ischemic Attack and Stroke
Dual antiplatelet Tx for stroke prevention: Worth the risk? | MDedge Family Medicine
THALES Secondary Efficacy | BRILINTA® (ticagrelor) tablets | For HCPs
Immediate aspirin after mini-stroke substantially reduces risk of major stroke | University of Oxford
A Comparison of Two Doses of Aspirin (30 mg vs. 283 mg a Day) in Patients after a Transient Ischemic Attack or Minor Ischemic Stroke | NEJM
Efficacy of Clopidogrel-Aspirin Regimen for TIA and Minor Stroke | Download Table
Contraindications to aspirin in suspected TIA | Download Table
Contraindications to aspirin in suspected TIA | Download Table
Stroke Guidelines | The International Aspirin Foundation
THALES: Ticagrelor Plus Aspirin Cuts Repeat Events After Stroke, TIA | tctmd.com
Life | Free Full-Text | Antithrombotic Therapy for Secondary Prevention in Patients with Non-Cardioembolic Stroke or Transient Ischemic Attack: A Systematic Review
Ischemic Benefit and Hemorrhage Risk of Ticagrelor-Aspirin Versus Aspirin in Patients With Acute Ischemic Stroke or Transient Ischemic Attack | Stroke
Dual Antiplatelet Therapy Versus Aspirin in Patients With Stroke or Transient Ischemic Attack: Meta-Analysis of Randomized Controlled Trials | Stroke
Drugs in secondary stroke prevention
Dual Antiplatelet Therapy Lowers Stroke, Death Rates in Ischemic Stroke/TIA Patients Better than Aspirin Alone - Physician's Weekly
Antithrombotic therapies (Chapter 18) - The Stroke Book
Antithrombotic therapy by cause of TIA - UpToDate
Cinnamon and Aspirin for Mild Ischemic Stroke or Transient Ischemic Attack: A Pilot Trial - ScienceDirect
Balancing Benefits and Risks of Long-Term Antiplatelet Therapy in Noncardioembolic Transient Ischemic Attack or Stroke | Stroke
Ticagrelor and Aspirin versus Aspirin in Acute Ischemic Stroke or TIA | NEJM
Time Course for Benefit and Risk of Ticagrelor and Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack | Neurology
